CGRP and the Trigeminal System in Migraine

被引:334
作者
Iyengar, Smriti [1 ]
Johnson, Kirk W. [1 ]
Ossipov, Michael H. [2 ]
Aurora, Sheena K. [1 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Syneos Hlth, Raleigh, NC USA
来源
HEADACHE | 2019年 / 59卷 / 05期
关键词
calcitonin gene-related peptide; migraine; nitric oxide; sensitization; trigeminal system; GENE-RELATED PEPTIDE; NITRIC-OXIDE SYNTHASE; CORTICAL SPREADING DEPRESSION; RECEPTOR ANTAGONIST BIBN4096BS; DOUBLE-BLIND; CLUSTER HEADACHE; TRIGEMINOVASCULAR NEURONS; EXTRACEREBRAL CIRCULATION; PREVENTIVE TREATMENT; EPISODIC MIGRAINE;
D O I
10.1111/head.13529
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-The goal of this narrative review is to provide an overview of migraine pathophysiology, with an emphasis on the role of calcitonin gene-related peptide (CGRP) within the context of the trigeminovascular system. Background.-Migraine is a prevalent and disabling neurological disease that is characterized in part by intense, throbbing, and unilateral headaches. Despite recent advances in understanding its pathophysiology, migraine still represents an unmet medical need, as it is often underrecognized and undertreated. Although CGRP has been known to play a pivotal role in migraine for the last 2 decades, this has now received more interest spurred by the early clinical successes of drugs that block CGRP signaling in the trigeminovascular system. Design.-This narrative review presents an update on the role of CGRP within the trigeminovascular system. PubMed searches were used to find recent (ie, 2016 to November 2018) published articles presenting new study results. Review articles are also included not as primary references but to bring these to the attention of the reader. Original research is referenced in describing the core of the narrative, and review articles are used to support ancillary points. Results.-The trigeminal ganglion neurons provide the connection between the periphery, stemming from the interface between the primary afferent fibers of the trigeminal ganglion and the meningeal vasculature and the central terminals in the trigeminal nucleus caudalis. The neuropeptide CGRP is abundant in trigeminal ganglion neurons, and is released from the peripheral nerve and central nerve terminals as well as being secreted within the trigeminal ganglion. Release of CGRP from the peripheral terminals initiates a cascade of events that include increased synthesis of nitric oxide and sensitization of the trigeminal nerves. Secreted CGRP in the trigeminal ganglion interacts with adjacent neurons and satellite glial cells to -perpetuate peripheral sensitization, and can drive central sensitization of the second-order neurons. A shift in central sensitization from activity-dependent to activity-independent central sensitization may indicate a mechanism driving the progression of episodic migraine to chronic migraine. The pathophysiology of cluster headache is much more obscure than that of migraine, but emerging evidence suggests that it may also involve hypersensitivity of the trigeminovascular system. Ongoing clinical studies with therapies targeted at CGRP will provide additional, valuable insights into the pathophysiology of this disorder. Conclusions.-CGRP plays an essential role in the pathophysiology of migraine. Treatments that interfere with the functioning of CGRP in the peripheral trigeminal system are effective against migraine. Blocking sensitization of the trigeminal nerve by attenuating CGRP activity in the periphery may be sufficient to block a migraine attack. Additionally, the potential exists that this therapeutic strategy may also alleviate cluster headache as well.
引用
收藏
页码:659 / 681
页数:23
相关论文
共 191 条
[1]  
Abdallah K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073022, 10.1371/annotation/7c794f90-1101-4196-8b10-4e3e320a7aac]
[2]   Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels [J].
Akerman, S ;
Williamson, DJ ;
Kaube, H ;
Goadsby, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (01) :62-68
[3]  
[Anonymous], 1988, NEUROSCIENCE, DOI DOI 10.1016/0306-4522(88)90018-8
[4]   Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura [J].
Antonova, Maria ;
Wienecke, Troels ;
Olesen, Jes ;
Ashina, Messoud .
CEPHALALGIA, 2012, 32 (11) :822-833
[5]   Heterogenous migraine aura symptoms correlate with visual cortex functional magnetic resonance imaging responses [J].
Arngrim, Nanna ;
Hougaard, Anders ;
Ahmadi, Khazar ;
Vestergaard, Mark Bitsch ;
Schytz, Henrik Winther ;
Amin, Faisal Mohammad ;
Larsson, Henrik Bo Wiberg ;
Olesen, Jes ;
Hoffmann, Michael B. ;
Ashina, Messoud .
ANNALS OF NEUROLOGY, 2017, 82 (06) :925-939
[6]   Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment [J].
Ashina, Hakan ;
Newman, Lawrence ;
Ashina, Sait .
NEUROLOGICAL SCIENCES, 2017, 38 (12) :2089-2093
[7]   Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial [J].
Ashina, M ;
Lassen, LH ;
Bendtsen, L ;
Jensen, R ;
Olesen, J .
LANCET, 1999, 353 (9149) :287-289
[8]   Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies [J].
Aurora, Sheena K. ;
Brin, Mitchell F. .
HEADACHE, 2017, 57 (01) :109-125
[9]   The occipital cortex is hyperexcitable in migraine: Experimental evidence [J].
Aurora, SK ;
Cao, Y ;
Bowyer, SM ;
Welch, KMA .
HEADACHE, 1999, 39 (07) :469-476
[10]   Brain excitability in migraine: evidence from transcranial magnetic stimulation studies [J].
Aurora, SK ;
Welch, KMA .
CURRENT OPINION IN NEUROLOGY, 1998, 11 (03) :205-209